BiomEdit: Funding, Investors & Team (Oct 2026)
BiomEdit is a company that uses innovative technology to develop new probiotics, bioactives, and microbial medicines for animal health. Their goal is to tackle important issues in animal agriculture and food security by harnessing the power of the microbiome. BiomEdit's unique platform uses high-throughput sequencing and data analytics to quickly identify and test new probiotic species and bioactive compounds. These can be modified to enhance production of beneficial substances or boost immune responses. These products are designed to improve animal health without relying on antibiotics.
BiomEdit has raised $18.4M across 1 funding round on record, the most recent a Series B of $18.4M announced in Jul 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BiomEdit Company Profile and Key Stats
Latest funding round on record: Jul 2025.
BiomEdit Funding Rounds
BiomEdit Founders and Leadership Team
Contact details for the BiomEdit team: 1 of 1 has an email address on file.
Start 14-day free trial →BiomEdit Funding Compared to Other Biotechnology Startups
BiomEdit's latest round of $18.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BiomEdit in Biotechnology and Fishers
Companies Similar to BiomEdit
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
BiomEdit Funding FAQs
What does BiomEdit do?
BiomEdit is a company that uses innovative technology to develop new probiotics, bioactives, and microbial medicines for animal health. Their goal is to tackle important issues in animal agriculture and food security by harnessing the power of the microbiome. BiomEdit's unique platform uses high-throughput sequencing and data analytics to quickly identify and test new probiotic species and bioactive compounds. These can be modified to enhance production of beneficial substances or boost immune responses. These products are designed to improve animal health without relying on antibiotics.
How much funding has BiomEdit raised?
BiomEdit has raised $18.4M across 1 round on record. The most recent is a Series B of $18.4M announced in Jul 2025.
When did BiomEdit last raise funding?
BiomEdit's most recent funding round on record is a Series B of $18.4M, announced in Jul 2025.
Who founded BiomEdit?
FundedIQ lists Aaron Schacht (Founder) at BiomEdit.
Where is BiomEdit headquartered?
BiomEdit is based in Fishers, Indiana, United States.
How many employees does BiomEdit have?
BiomEdit is in the 11-50 employee band.
How does BiomEdit's funding compare to other Biotechnology startups?
BiomEdit's latest round of $18.4M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BiomEdit Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BiomEdit is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.